Table 2.

Lesions and procedural characteristics

Variable	Lesion based
	Absorb scaffold (N = 179)	Everolimus-DES (N = 65)	p value
Target vessel:
LM	4 (2.2%)	15 (23.1%)	< 0.001
LAD	100 (55.9%)	40 (61.5%)	0.428
LCX	35 (19.6%)	12 (18.4%)	0.863
RCA	43 (24.0%)	10 (15.4%)	0.148
SVG	1 (0.6%)	1 (1.5%)	0.463
ACC/AHA lesion class B2/C	116 (64.8%)	46 (70.8%)	0.383
	Scaffold/stent based
	Absorb scaffold (n = 245)	Everolimus-DES (n = 82)	p value
Bifurcation stenting	18 (7.3%)	17 (20.7%)	< 0.001
Moderate/severe calcification	86 (35.1%)	38 (46.3%)	0.069
Thrombus	24 (9.8%)	5 (6.1%)	0.308
Overlap	141 (57.6%)	59 (72.0%)	0.020
In-stent implantation	15 (6.1%)	28 (34.1%)	< 0.001
Chronic total occlusion	11 (4.5%)	3 (3.7%)	0.74
Pre-dilatation	231 (94.3%)	71 (86.6%)	0.023
Pre-dilatation NC-balloon	161 (65.7%)	37 (45.1%)	0.001
Pre-dilatation cutting balloon	24 (9.8%)	19 (23.2%)	0.002
Pre-dilatation balloon/device diameter-ratio	0.96 ± 0.11	0.90 ± 0.13	< 0.001
Pre-dilatation inflation pressure/atm	14.38 ± 3.92	13.79 ± 3.64	0.464
Stent inflation pressure/atm	11.95 ± 2.67	12.70 ± 2.87	0.099
Stent inflation time/sec	76.66 ± 18.00	16.50 ± 5.57	< 0.001
Post-dilatation NC-balloon	235(95.9%)	81 (98.8%)	0.303
Post-dilatation balloon/device diameter ratio	1.10 ± 0.09	1.08 ± 0.12	0.025
Post-dilatation balloon-device diameter/mm	0.34 ± 0.25	0.29 ± 0.34	0.04
Post-dilatation inflation pressure/atm	17.89 ± 4.04	16.84 ± 4.03	0.028
Post-dilatation inflation time/sec	15.88 ± 6.22	13.70 ± 3.44	0.004
Device success	239 (97.6%)	81 (98.8%)	0.685
Use of bailout device	25 (10.2%)	1 (1.2%)	0.009

Plus–minus values are means ± SD

ACC/AHA American College of Cardiology/American Heart Association, DES drug-eluting stents, LM left main, LAD left anterior descending, LCX left circumflex, NC non-compliant, RCA right coronary artery, SVG saphenous vein graft